breast pathology presentation

Содержание

Слайд 2

Pathology of the breast normal anatomy physiologic changes developmental abnormalities inflammations

Pathology of the breast

normal anatomy
physiologic changes
developmental abnormalities

inflammations
fibrocystic changes
tumors
benign
malignant
pathology of the male breast
Слайд 3

Normal anatomy before puberty – breasts in both sexes – ducts

Normal anatomy

before puberty – breasts in both sexes – ducts


variable degrees of branching, lack lobules
15 to 25 lactiferous ducts
start in the nipple – branch terminal ductal lobular unit (intralobular duct, multiple lobular ducts, ductules or acini + intralobular connective tissue)
hormonally responsive
Слайд 4

Physiologic changes at birth male and female breasts active secretion (transplacental

Physiologic changes

at birth male and female breasts
active secretion (transplacental

passage of maternal hormones) bilateral breast enlargement
colostrum-like secretion ("witch's milk")
recedes several months postpartum
after menopause – gradual and progressive involution (lobular atrophy, increased fat, cystic dilatation of ducts)
Слайд 5

Macromastia diffuse enlargement of both breasts adolescence or pregnancy exaggerated response

Macromastia
diffuse enlargement of both breasts
adolescence or pregnancy

exaggerated response to hormonal stimulation
Pubertal (Virginal) Macromastia
1669 - 23-year-old woman - breasts enlarged "overnight" to a combined weight of 104 pounds
Pregnancy
1 in 100,000 pregnancies - erythematous, edematous, painful

Physiologic changes

Слайд 6

Developmental abnormalities Aplasia and hypoplasia uncommon – associated with overdevelopment of

Developmental abnormalities

Aplasia and hypoplasia
uncommon – associated with overdevelopment of

the contralateral breast
acquired (irradiation – chest wall tumors)
unilateral or bilateral amastia (absence of a nipple, breast ducts, pectoralis major muscle) – sex-linked recessive inheritance
Слайд 7

Слайд 8

Ectopic breast supernumerary breast (from ectopic breast tissue – along the

Ectopic breast
supernumerary breast (from ectopic breast tissue – along the

milk lines (midaxillae – normal breasts – medial groin and vulva)
1 – 6 % of adult women, much less often in men
unilateral axillary breast tissue
Polythelia
areola and underlying mammary ducts
Aberrant Breast
beyond the usual anatomic extent (no nipple or areola)

Developmental abnormalities

Слайд 9

Слайд 10

Inflammatory and reactive conditions Fat necrosis can simulate carcinoma clinically and

Inflammatory and reactive conditions

Fat necrosis
can simulate carcinoma clinically and

mammographically
history of antecedent trauma, prior surgical intervention)
histiocytes with foamy cytoplasm
lipid–filled cysts
fibrosis, calcifications, egg shell on mammography
Слайд 11

Inflammatory and reactive conditions Hemorrhagic necrosis with coagulopathy Warfarin treatment –

Inflammatory and reactive conditions

Hemorrhagic necrosis with coagulopathy
Warfarin treatment – shortly

after initiation
edema, hemorrhage, necrosis (thrombi in small blood vessels )
protein C deficiency
Breast augmentation
foreign materials (shellac, glazier's putty, spun glass, epoxy resin, beeswax, and shredded silk, silicone)
thin–walled silicone bag – capsule – disfiguration
Слайд 12

Puerperal mastitis early stages (2nd and 3rd W) of lactation –

Puerperal mastitis
early stages (2nd and 3rd W) of lactation

– 5%
stasis of milk in distended ducts + staphylococci
abscess formation (ATB, incision and drainage)
Granulomatous Lobular Mastitis
etiology unknown, suggests carcinoma
Mammary duct ectasia
periductal inflammation, duct sclerosis
intermittent nipple discharge
Tuberculosis
less developed regions - serious condition
lactating breast, innoculation via the lactiferous ducts
slowly growing, solitary, painless mass
Слайд 13

Слайд 14

Benign proliferative lesions pathologic spectrum of seemingly related clinically benign breast

Benign proliferative lesions

pathologic spectrum of seemingly related clinically benign breast

abnormalities
palpably irregular and painful breasts
discrete lumps, multiple nodules, cystically dilated ducts, apocrine metaplasia, interlobular and intralobular fibrosis
intraductal epithelial proliferation
fibrocystic disease, fibrocystic changes
extremely common (58% F)
Слайд 15

Benign proliferative lesions Adenosis elongation of the terminal ductules caricature of

Benign proliferative lesions

Adenosis
elongation of the terminal ductules caricature of

the lobule
sclerosing adenosis
apocrine adenosis
tubular adenosis
nonpalpable lesion, recognized in mammograms
microcalcifications!
Слайд 16

Benign tumors Fibroadenoma proliferation of epithelial and stromal elements most common

Benign tumors

Fibroadenoma
proliferation of epithelial and stromal elements
most common breast

tumor in adolescent and young adult women (peak age = third decade)
higher incidence in black patients
well-circumscribed, freely movable, nonpainful mass
regress with age if left untreated
ducts distorted elongated slit-like structures - intracanalicular pattern, ducts not compressed
pericanalicular growth pattern (little practical value)
Слайд 17

Tubular adenoma far less common than fibroadenomas young women, discrete, freely

Tubular adenoma
far less common than fibroadenomas
young women, discrete, freely

movable masses
uniform sized ducts
Lactating Adenoma
enlarging masses during lactation or pregnancy
prominent secretory change
Intraductal papilloma
in the mammary ducts, subareolar lactiferous ducts
periductal inflammation, duct sclerosis
serous or bloody nipple discharge
fibrosis, infarction, squamous metaplasia
Слайд 18

Слайд 19

Cystosarcoma phyllodes (phyllodes tumor) initial description - over 150 years ago

Cystosarcoma phyllodes (phyllodes tumor)

initial description - over 150 years ago -

fleshy tumor, leaf-like pattern and cysts on cut surface
circumscribed, connective tissue and epithelial elements (× fibroadenomas = greater connective tissue cellularity), 1-15 cm
less than 1 % of breast tumors
benign, malignant
metastases are hematogenous

low grade
high grade

Слайд 20

Слайд 21

Слайд 22

Proliferative changes ductal and lobular hyperplasia atypical ductal and lobular hyperplasia

Proliferative changes

ductal and lobular hyperplasia
atypical ductal and lobular hyperplasia

higher risk for the cancer than "normal" population
associated w. microcalcifications (!mammography!)
incidental histological finding
atypical hyperplasia = precancerous lesion
Слайд 23

Breast carcinoma most frequent malignant tumor in females (followed by cervix

Breast carcinoma

most frequent malignant tumor in females (followed by cervix

and colon)
highest incidence – developed countries
(USA 84,8/100 000F/Y, Western Europe 64,7/100 000F/Y)
2nd killer among cancers (1st = lung ca)
risk factors: genetic predisposition (breast ca in close (1st degree) relatives), proliferative changes, early menarche, late menopause, history of ca (breast, ovary, endometrium)
importance of preventive controls! – early diagnosis better prognosis
Слайд 24

Breast carcinoma - classification IN SITU INVASIVE DUCTAL LOBULAR Ductal in

Breast carcinoma - classification

IN SITU
INVASIVE

DUCTAL
LOBULAR

Ductal in situ (intraductal)

Lobular

in situ

Ductal invasive

Lobular invasive

+ other types (12)

Слайд 25

Carcinoma in situ preinvasive - does not form a palpable tumor

Carcinoma in situ

preinvasive - does not form a palpable tumor

not detected clinically (only X-ray – screening !!!)
multicentricity and bilaterality (namely LCIS)
continuum: bland hyperplasia - increasing atypism - carcinoma in situ
no metastatic spread (basement membrane)
risk of invasion depending on grade
Слайд 26

Invasive carcinoma Invasive ductal carcinoma largest group (65 to 80 %

Invasive carcinoma

Invasive ductal carcinoma
largest group (65 to 80 % of

mammary carcinomas)
mid to late fifties
stellate, white, firm (desmoplasia)
less often circumscribed, soft (medullary ca)
hormonally dependent (estrogen, progesterone)
Invasive lobular carcinoma
uniform cells, infiltrative growth (linear arrangement - indian file pattern)
Слайд 27

other types: tubular, mucinous, medullary, inflammatory – together about 10 %

other types: tubular, mucinous, medullary, inflammatory – together about 10

% of breast ca
metastases: regional lymph nodes (axillary, parasternal), lungs, liver, bone marrow, brain
treatment: surgery (radical – mastectomy, breast conserving surgery – lumpectomy),
radiotherapy
antihormonal therapy (Tamoxifen)
chemotherapy

Invasive carcinoma

Слайд 28

Paget‘s disease of the nipple result of intraepithelial spread of intraductal

Paget‘s disease of the nipple

result of intraepithelial spread of intraductal

carcinoma
large pale-staining cells within the epidermis of the nipple
limited to the nipple or extend to the areola
pain or itching, scaling and redness, mistaken for eczema
ulceration, crusting, and serous or bloody discharge
Слайд 29

Paget’s disease

Paget’s disease

Слайд 30

PAGET’S DISEASE OF NIPPLE Rare manifestation of breast CA. U/l erythematous

PAGET’S DISEASE OF NIPPLE

Rare manifestation of breast CA.
U/l erythematous eruption, Pruritus.
Malignant

cells/PAGET CELLS ? Extend from DCIS within ductal system – via lactiferous sinuses ? nipple skin without crossing the BM.
Tumour cells – disrupt tight squamous epithelial barrier – ECF seeps out onto nipple surface ? oozing scaly crust.
Paget’s cells – detected by nipple Bx/cytological preparation of the exudate.
Palpable mass ? 50 – 60 % of women => invasive CA.
No palpable mass => DCIS
Poorly differentiated, ER Negative, HER2/neu overexp.
Prognosis – depends on features of underlying Ca.
Слайд 31

Pathology of the male breast Gynecomastia most common clinical and pathologic

Pathology of the male breast

Gynecomastia
most common clinical and pathologic abnormality

of the male breast
increase in subareolar tissue
in 30 to 40 percent of adult males, both breasts are affected in many cases
associated with hyperthyroidism, cirrhosis of the liver, chronic renal failure, chronic pulmonary disease, and hypogonadism, use of hormones - estrogens, androgens, and other drugs (digitalis, cimetidine, spironolactone, marihuana, and tricyclic antidepressants)
Carcinoma of the male breast
uncommon < 1 % of all breast cancers
Слайд 32

Слайд 33